Publications by authors named "Kaita Sugiyama"

Article Synopsis
  • The study aimed to find out which factors might lead to a relapse of rheumatoid arthritis (RA) symptoms when patients reduce their methotrexate (MTX) dose while on a combination therapy with golimumab (GLM).* -
  • Researchers analyzed data from 304 RA patients, noting that 16.8% of those who reduced their MTX dosage experienced a relapse; factors such as history of cardiovascular disease, gastrointestinal disease, and liver disease were found to increase the odds of relapse.* -
  • The findings suggest that doctors should carefully consider these health histories, along with previous use of non-steroidal anti-inflammatory drugs (NSAIDs), before deciding to reduce MTX doses in RA patients to minimize the risk
View Article and Find Full Text PDF

A 38-year-old woman had a history of asthma for 20 years. Bullous lesions had appeared on her left side of the back. Two months before admission, the biopsy revealed eosinophilic cellulitis.

View Article and Find Full Text PDF

Objectives: Conventionally, some patients with methotrexate-associated lymphoproliferative disorder (MTX-LPD) undergo spontaneous tumour regression after cessation of MTX. Although the involvement of Epstein-Barr virus (EBV) in the development and spontaneous regression has been suggested, the underlying mechanism remains unknown. In this study, we analysed patients who had developed MTX-LPD to evaluate the association between the development and spontaneous regression of MTX-LPD with EBV.

View Article and Find Full Text PDF

A 26-year-old woman presented with abdominal pain, diarrhoea, vomiting, fever, and progressive paralysis in the lower limbs. She had a history of bronchial asthma and experienced sinusitis, progressive peripheral neuropathy, polyarthritis, and leukocytosis with prominent eosinophilia. The patient was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA).

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the risk of major cardiovascular events in patients with primary Sjögren syndrome (pSS) by assessing myocardial fibrosis using cardiac magnetic resonance imaging (cMRI).
  • It involved 52 women aged around 55, where 19% showed signs of myocardial fibrosis, even without any cardiac symptoms.
  • The findings indicate a link between abnormal cMRI results and severe salivary gland involvement in pSS patients, suggesting potential underlying heart issues despite the absence of symptoms.
View Article and Find Full Text PDF

Aim: To evaluate left ventricular (LV) dysfunction in patients with rheumatoid arthritis (RA) and to determine the impact of biological treatment on LV function in these patients using global circumferential strain (GCS), global longitudinal strain (GLS) and global radial strain (GRS) values assessed by feature tracking cardiac magnetic resonance (FT-CMR) imaging.

Methods: Eighty patients with RA and 20 controls without cardiovascular disease underwent non-contrast CMR imaging. Patients with RA received conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or biologic DMARDs (bDMARDs).

View Article and Find Full Text PDF

Aim: This study aimed to evaluate the association between myocardial abnormalities and left ventricular (LV) geometry as assessed using cardiac magnetic resonance imaging (CMRI) in systemic sclerosis (SSc) patients without cardiac symptoms.

Methods: SSc patients without cardiac symptoms or cardiovascular risk factors underwent contrast CMRI. CMRI were assessed for structural and functional LV parameters and myocardial fibrosis based on myocardial late gadolinium enhancement (LGE).

View Article and Find Full Text PDF

Objectives: Minodronic acid hydrate, an oral bisphosphonate, has a greater inhibitory effect on bone resorption than do other approved drugs; however, this has been studied only in patients with primary osteoporosis. Here, we administered minodronic acid hydrate to patients with steroid-induced osteoporosis who have been treated with steroids for rheumatoid arthritis or other collagen diseases, and the efficacy and safety of minodronic acid hydrate were prospectively investigated.

Methods: Twenty-five patients treated in our rheumatology clinic received minodronic acid hydrate 1 mg/day.

View Article and Find Full Text PDF

We report a 68-years-old woman with systemic sclerosis and interstitial pneumonia (IP). She had developed subacute progressively encephalopathy and dementia while treated with oral cyclophosphamide and prednisolone. She admitted to our hospital because of syncope.

View Article and Find Full Text PDF